Lv4
486 积分 2022-10-13 加入
IncobotulinumtoxinA Versus OnabotulinumtoxinA for Treatment of Overactive Bladder Syndrome: A Randomized Single-blinded Non-inferiority Trial
7天前
已关闭
IncobotulinumtoxinA vs OnabotulimuntoxinA for Treatment of Overactive Bladder Syndrome: A Randomized Single-Blinded Non-Inferiority Trial
7天前
已关闭
OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial
20天前
已完结
The Efficacy and Safety of Dermagraft in Improving the Healing of Chronic Diabetic Foot Ulcers
25天前
已完结
Macrophage stimulating agent soluble yeast β‐1,3/1,6‐glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo‐controlled phase II study
25天前
已完结
陈飞,狄文,胡元晶等.外用红色诺卡菌细胞壁骨架治疗子宫颈高危型HPV持续感染的有效性及安全性研究
25天前
已关闭
A Randomized, Controlled Trial of Promogran (a Collagen/Oxidized Regenerated Cellulose Dressing) vs Standard Treatment in the Management of Diabetic Foot Ulcers
25天前
已完结
Pharmacokinetics of Liposomal Amphotericin B for Injection in Chinese Healthy Subjects Based on a Bioequivalence Study
1个月前
已完结
Pharmacokinetic Equivalence of AmphosomTM, a Newly Developed Liposomal Amphotericin B, to AmbisomeⓇ
1个月前
已完结
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products
1个月前
已完结
皖公网安备34019202002308
